SOL SpA
MIL:SOL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
25.6
37.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
SOL SpA
SOL SpA
Income from Continuing Operations
SOL SpA
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SOL SpA
MIL:SOL
|
Income from Continuing Operations
€147.8m
|
CAGR 3-Years
7%
|
CAGR 5-Years
23%
|
CAGR 10-Years
N/A
|
|
SOL SpA
Glance View
SOL SpA engages in the production, research, and distribution of industrial and medicinal gases; door-to-door medical care; and related medical equipment. The company is headquartered in Monza, Monza E Brianza. The company is also involved in the home care medical business. The Company’s product portfolio includes oxygen, nitrogen, hydrogen, argon, sulfur hexafluoride, carbon dioxide, ozone, helium and mixtures of medicinal gases, among others. Through its subsidiaries, the Company is involved in the provision of home care services, such as oxygen therapy, mechanical ventilation, diagnosis and care of obstructive sleep apnea syndrome, artificial nutrition, telemedicine, health assistance, and the prevention and treatment of skin ulcers. Additionally, it is engaged in the supply and management of medical and technological devices for home care. As of December 31, 2011, the Company had a number of subsidiaries, including Airsol BV, Biotechsol Srl, CTS Srl, Energetika ZJ doo, GTH Gaze Industriale SA, Cryolab Srl, GTS Shpk and Hydroenergy Shpk, among others.
See Also
What is SOL SpA's Income from Continuing Operations?
Income from Continuing Operations
147.8m
EUR
Based on the financial report for Jun 30, 2024, SOL SpA's Income from Continuing Operations amounts to 147.8m EUR.
What is SOL SpA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
23%
Over the last year, the Income from Continuing Operations growth was -4%. The average annual Income from Continuing Operations growth rates for SOL SpA have been 7% over the past three years , 23% over the past five years .
You don't have any saved screeners yet
